Ingrid Marksteiner
About Ingrid Marksteiner
Ingrid Marksteiner is a Klinikreferentin Immun Onkologie at Bristol-Myers Squibb in New Jersey, United States, with extensive experience in immuno-oncology.
Title
Ingrid Marksteiner holds the title of Klinikreferentin Immun-onkologie at Bristol-Myers Squibb. In this capacity, she engages directly with healthcare providers to support advancements in immuno-oncology treatments.
Company
Ingrid Marksteiner is currently employed by Bristol-Myers Squibb, a global biopharmaceutical company based in New Jersey, United States. The company is renowned for its innovative treatments in the field of oncology and immunology.
Previous Positions
Before joining Bristol-Myers Squibb in March 2015, Ingrid Marksteiner served as a Key Account Manager at Biogen Idec Austria GmbH. This role involved managing significant client accounts and contributing to the company's commercial success.
Experience in Immuno-Oncology
Ingrid Marksteiner has extensive experience in the field of immuno-oncology, which is a branch of medicine focused on using the body's immune system to combat cancer. Her expertise ensures impactful contributions to the development and dissemination of cutting-edge cancer treatments.